Observational Study of the Durability of Seroconversion Chronic HBV Patients Who Seroconverted in a Previous Gilead-Sponsored Study of ADV.
NCT00158717
·
clinicaltrials.gov ↗
COMPLETED
Status
107
Enrollment
INDUSTRY
Sponsor class
Conditions
Hepatitis B
Interventions
DRUG:
Hepsera
Sponsor
Gilead Sciences